CN1972705B - 硫糖肽在治疗粘膜炎中的用途 - Google Patents

硫糖肽在治疗粘膜炎中的用途 Download PDF

Info

Publication number
CN1972705B
CN1972705B CN2005800159271A CN200580015927A CN1972705B CN 1972705 B CN1972705 B CN 1972705B CN 2005800159271 A CN2005800159271 A CN 2005800159271A CN 200580015927 A CN200580015927 A CN 200580015927A CN 1972705 B CN1972705 B CN 1972705B
Authority
CN
China
Prior art keywords
sulglicotide
mucositis
treatment
mucosa
purposes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2005800159271A
Other languages
English (en)
Chinese (zh)
Other versions
CN1972705A (zh
Inventor
M·亚科贝利
L·I·费罗
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gentium SRL
Original Assignee
Gentium SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gentium SRL filed Critical Gentium SRL
Publication of CN1972705A publication Critical patent/CN1972705A/zh
Application granted granted Critical
Publication of CN1972705B publication Critical patent/CN1972705B/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN2005800159271A 2004-05-18 2005-05-12 硫糖肽在治疗粘膜炎中的用途 Expired - Fee Related CN1972705B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT000989A ITMI20040989A1 (it) 2004-05-18 2004-05-18 Uso del sulglicotide per iul trattamento delle mucositi
ITMI2004A000989 2004-05-18
PCT/IT2005/000272 WO2005110458A1 (en) 2004-05-18 2005-05-12 Use of sulglicotide for the treatement of mucositis

Publications (2)

Publication Number Publication Date
CN1972705A CN1972705A (zh) 2007-05-30
CN1972705B true CN1972705B (zh) 2011-11-02

Family

ID=34971240

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2005800159271A Expired - Fee Related CN1972705B (zh) 2004-05-18 2005-05-12 硫糖肽在治疗粘膜炎中的用途

Country Status (9)

Country Link
US (1) US7662777B2 (https=)
EP (1) EP1747010B1 (https=)
JP (1) JP4874962B2 (https=)
CN (1) CN1972705B (https=)
BR (1) BRPI0511165A (https=)
CA (1) CA2565084C (https=)
IL (1) IL178907A0 (https=)
IT (1) ITMI20040989A1 (https=)
WO (1) WO2005110458A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101851285B (zh) * 2009-04-03 2012-09-12 四川德博尔制药有限公司 硫酸糖肽的制备方法
KR101819709B1 (ko) * 2017-01-13 2018-01-17 (주)아이엠디팜 설글리코타이드 또는 이의 약학적으로 허용가능한 염을 포함하는 안구건조증의 예방 또는 치료용 약학 조성물
KR102863615B1 (ko) * 2022-07-11 2025-09-24 삼일제약 주식회사 생체이용률이 개선된 설글리코타이드를 유효성분으로 포함하는 염증성 질환의 예방 또는 치료용 약제학적 조성물 및 그 제조방법
CN115845127B (zh) * 2022-12-29 2023-11-24 海南众森生物科技有限公司 一种多糖止血修复生物胶液及其制备方法和用途
CN116440036B (zh) * 2023-04-12 2024-10-29 燕园同创生物科技(北京)有限公司 一种修复美白护龈固齿牙膏及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1215332B (it) 1987-01-12 1990-02-08 Crinos Industria Farmaco Composizione farmaceutica contenente sulglicotide per la terapia dell'ulcera gastrica
WO1992018153A1 (en) 1991-04-12 1992-10-29 Creative Biomolecules, Inc. Method of treating gastrointestinal ulcers with platelet derived growth factor
US5496828A (en) 1994-08-22 1996-03-05 Eli Lilly And Company Methods of inhibiting ulcerative mucositis
WO2003024391A2 (en) * 2001-08-16 2003-03-27 Mucosal Therapeutics, Inc. Treatment and prevention of mucositis in cancer patients
AU2003230952A1 (en) * 2002-05-21 2003-12-12 Abbott Laboratories Treatment of mucositis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PIOTROWSKI J ET AL.Enhancement in Gastric Mucosal EGF and PDGFReceptorExpression with Ulcer Healing by Sulglycotide.Gen. Pharmacol26 4.1995,749-753. *

Also Published As

Publication number Publication date
EP1747010B1 (en) 2015-01-21
US20080234180A1 (en) 2008-09-25
JP2007538066A (ja) 2007-12-27
CN1972705A (zh) 2007-05-30
EP1747010A1 (en) 2007-01-31
JP4874962B2 (ja) 2012-02-15
BRPI0511165A (pt) 2007-12-04
ITMI20040989A1 (it) 2004-08-18
US7662777B2 (en) 2010-02-16
WO2005110458A1 (en) 2005-11-24
CA2565084A1 (en) 2005-11-24
IL178907A0 (en) 2007-03-08
CA2565084C (en) 2013-09-03

Similar Documents

Publication Publication Date Title
Chaveli-López et al. Treatment of oral mucositis due to chemotherapy
Kochhar et al. Natural history of late radiation proctosigmoiditis treated with topical sucralfate suspension
US20080233206A1 (en) Compositions and methods for anti-inflammatory treatments
RU2227033C2 (ru) Тауролидин и/или таурултам при лечении инфекционной язвенной болезни или инфекционного гастрита
Efthymakis et al. The role of Zinc L-Carnosine in the prevention and treatment of gastrointestinal mucosal disease in humans: a review.
JP2012533559A (ja) アセトアミノフェンの治療効果を改善するためのｎ−アセチルシステイン組成物および方法
CN1972705B (zh) 硫糖肽在治疗粘膜炎中的用途
Kak Rebamipide in gastric mucosal protection and healing: An Asian perspective
US20080085314A1 (en) Solid oral formulations for combination therapy
EP1656120B1 (en) Compositions comprising components coated with a liquid impermeable but gas permeable layer, use thereof for treating cutaneous and other exocrine gland diseases
KR100883999B1 (ko) 점막염 치료를 위한 설글리코타이드의 용도
CA2185883C (en) The use of dimeticone as a transport and carrier system and/or drug delivery system
Lanza A review of mucosal protection by synthetic prostaglandin E analogs against injury by nonsteroidal anti-inflammatory agents
ES2980614T3 (es) Composición farmacéutica que contiene lisozima y uso de la misma
CN113425713B (zh) 一种治疗十二指肠溃疡的药物组合物
US5135925A (en) Use of zinc acexamate in the prophylaxis of gastropathy induced by non-steroidal anti-inflammatory drugs
CN101313898A (zh) 一种用于治疗胃肠道疾病的组合物
Horwhat et al. Radiation enteritis
RU2002121267A (ru) Способ профилактики и лечения язв желудка у животных
JPH01132529A (ja) 消化器系疾患治療剤
Prucksunand et al. Prevention action of turmeric against HCl-induced gastric necrosis in rat: to verify the mode of action of previous clinical study
US20080145409A1 (en) Composition for the treatment and prevention of peptic ulcer
Bakuridze et al. FORMULATION AND TECHNOLOGY OF TARGETED DELIVERY AND MODIFIED-RELEASE SYSTEMS
NZ545365A (en) Compositions comprising components coated with a liquid impermeable but gas permeable layer, use thereof for treating cutaneous and other exocrine gland diseases
AU2010344311B2 (en) Composition and method for treating ulcers

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20111102

Termination date: 20150512

EXPY Termination of patent right or utility model